Post Type Archives: News

Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania. The new facility is designed to support biopharma customers with applications and process development for the purification of biotherapeutic molecules, providing comprehensive technical support to biopharmaceutical companies and contract manufacturers operating from small-scale to full commercial production. This […]

GSK plc and Boston Pharmaceuticals, a leading clinical stage biopharmaceutical company developing highly targeted therapies for patients with serious liver diseases, today announced that they have entered into an agreement under which GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa. Efimosfermin is a phase III-ready, potential best-in-class, investigational specialty medicine to treat and prevent […]

Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (API) for the pharmaceutical and biotech sectors, is pleased to announce the appointment of Elizabeth Rebeil as Global Vice President of Supply Chain and Operational Excellence. Ms. Rebeil brings more than 20 years of experience in supply chain management and continuous […]

FAMAR Group, a leading European pharmaceutical CDMO, is pleased to announce the signature of an agreement to acquire a sterile production site in Homburg (Saar), Germany, from MiP Pharma. The acquisition represents a strategic milestone in FAMAR’s growth journey, strengthening its footprint in high-value dosage forms and expanding its capabilities in aseptic and lyophilized fill […]

Combines Recipharm’s development and manufacturing capabilities with PLG’s product development expertise and regulatory affairs experience Reduces timelines to first-in-human clinical trials and market approvals, through the combined expertise of two leaders in product development Benefits patients suffering from diseases with high unmet medical needs Recipharm, a leading global contract development and manufacturing organisation (CDMO), and […]

Piramal Pharma Limited, a leading global pharmaceuticals and wellness company, in conjunction with the 2025 SelectUSA Investment Summit, commits to a $90M investment plan towards expanding two of the Company’s US facilities. These expansions are in response to ongoing demand from US customers, in support of the trend towards US onshoring of drug supply, and […]

Lonza Group Ltd held its Annual General Meeting (AGM), led by the Chair of the Board of Directors, Jean-Marc Huët. 59.33% of the share capital was represented at the AGM, with attending and represented shareholders collectively holding a total of 42,854,574 shares. All Board members standing for re-election were re-elected, each for a further term […]

Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, has published a report analyzing recent trends in obesity-related clinical trials. The report shows that the number of these trials tripled between 2019 and 2024, reflecting increased research activity and broader range of potential therapeutic options for obesity treatments. Obesity continues to represent […]

In its qualitative Q1 2025 update, Lonza reported a strong performance across its CDMO business in line with the Full-Year Outlook 2025. CHI progressed successfully on its recovery path in line with its Full-Year 2025 expectations. In Biologics, there was good momentum across the division, supported by a strong performance in Mammalian and Bioconjugates. Commercial […]

GeneFab, a next-generation cell and gene therapy-focused contract research, development, and manufacturing organization (CRDMO), has partnered with RegCell, a biotech company advancing regulatory T cell (Treg) therapies for autoimmune diseases. This collaboration will see GeneFab support the tech transfer and clinical manufacturing of RegCell’s Treg platform as it transitions from Japan to GeneFab’s manufacturing facility […]